X
Keytruda approved for bladder cancer in Europe, first to prove survival benefit
https://pharmaphorum.com/news/keytruda-approved-bladder-cancer-europe-first-prove-survival-benefit/
Keytruda
FDA probes blood cancer immunotherapy safety
September 1, 2017Regulator reviewing combination therapy safety after issue with Keytruda
Merck soars on Keytruda combination filing
January 12, 2017Approval by May could put Keytruda in pole position
Merck and Lilly expand alliance with Keytruda + Lartruvo trial
January 11, 2017
Cancer market commentary: Roche’s Tecentriq muscles into NSCLC
October 10, 2016Roche’s PD-L1 drug has generated impressive data in second line lung cancer
Cancer Market Commentary: Keytruda’s triumph not the last word in NSCLC
October 10, 2016Despite Keytruda’s overwhelming victory, it’s not over yet in NSCLC
Eye on ESMO: Day 1 – Access in spotlight before data deluge
October 8, 2016Europe’s biggest cancer conference ESMO is underway
Merck makes its move: Keytruda filed for first line lung cancer
September 7, 2016Merck steals a march on rival BMS.
1 2
